financetom
Business
financetom
/
Business
/
Northwest Natural's Board Elects Justin Palfreyman as Chief Executive
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Northwest Natural's Board Elects Justin Palfreyman as Chief Executive
Mar 3, 2025 4:56 AM

07:33 AM EST, 03/03/2025 (MT Newswires) -- Northwest Natural Holdings (NWN) said Monday its board has elected Justin B. Palfreyman as its new chief executive officer, effectve April 1.

Palfreyman will succeed David H. Anderson, who is retiring from the company.

Palfreyman has been with the company since 2016 and was promoted as Northwest Natural's ( NWN ) president in 2023, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exp World Holdings Insider Sold Shares Worth $555,028, According to a Recent SEC Filing
Exp World Holdings Insider Sold Shares Worth $555,028, According to a Recent SEC Filing
Aug 14, 2024
01:21 PM EDT, 08/14/2024 (MT Newswires) -- Glenn Darrel Sanford, 10% Owner, Director, CEO and Chairman of the Board, on August 13, 2024, sold 46,047 shares in Exp World Holdings ( EXPI ) for $555,028. Following the Form 4 filing with the SEC, Sanford has control over a total of 41,074,250 shares of the company, with 41,074,250 shares held directly....
Equinor, Dominion are winners in US Central Atlantic offshore wind auction
Equinor, Dominion are winners in US Central Atlantic offshore wind auction
Aug 14, 2024
Aug 14 (Reuters) - A U.S. government sale of offshore wind development rights for two areas off the coasts of Delaware, Maryland and Virginia yielded nearly $93 million in winning bids, the Interior Department said on Wednesday. The winning bidders were Norway's Equinor ( EQNR ) and Virginia Electric and Power Co, a division of U.S. utility Dominion. ...
US FDA approves Gilead's liver disease drug
US FDA approves Gilead's liver disease drug
Aug 14, 2024
Aug 14 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences' ( GILD ) drug for a chronic and potentially fatal liver disease that mostly affects women. The disease, primary biliary cholangitis (PBC), causes inflammation of the small bile ducts in the liver and can eventually destroy them. It mainly affects women aged...
Market Chatter: Johnson & Johnson to Announce Majority Support for $6.48 Billion Talc Settlement
Market Chatter: Johnson & Johnson to Announce Majority Support for $6.48 Billion Talc Settlement
Aug 14, 2024
01:20 PM EDT, 08/14/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) is set to announce wider support for a $6.48 billion settlement to resolve tens of thousands of lawsuits claiming its talc products, including Baby Powder, caused cancer, Reuters reported Wednesday, citing people familiar with the matter. The company intends to disclose that more than 75% of claimants...
Copyright 2023-2026 - www.financetom.com All Rights Reserved